141 related articles for article (PubMed ID: 11365597)
1. HIV-specific immune responses restored by HIV immunogen plus antiretroviral suppression.
James JS
AIDS Treat News; 1998 Jul; (No 298):1-5. PubMed ID: 11365597
[TBL] [Abstract][Full Text] [Related]
2. Rebuilding immunity with Remune.
Whitfield L
Posit Aware; 1998; 9(3):39-40. PubMed ID: 11365486
[TBL] [Abstract][Full Text] [Related]
3. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
[TBL] [Abstract][Full Text] [Related]
4. Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE) therapy in Thailand.
Chantratita W; Sukeepaisarncharoen W; Chandeying V; Kulpradist S; Israngkura Na Ayudhtaya B; Rugpao S; Sirawaraporn W; Boonshuyar C; Churdboonchart V
HIV Med; 2004 Sep; 5(5):317-25. PubMed ID: 15369506
[TBL] [Abstract][Full Text] [Related]
5. Remune trial will stop; new trials planned.
James JS
AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461
[TBL] [Abstract][Full Text] [Related]
6. A boost for the immune system.
TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925
[TBL] [Abstract][Full Text] [Related]
7. Agouron and immune response to commercialize remune immune-based treatment.
James JS
AIDS Treat News; 1998 Jun; (No 297):1. PubMed ID: 11365593
[TBL] [Abstract][Full Text] [Related]
8. A primer on HIV type 1-specific immune function and REMUNE.
Moss RB; Giermakowska WK; Savary JR; Theofan G; Daigle AE; Richieri SP; Jensen FC; Carlo DJ
AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S167-75. PubMed ID: 9672235
[TBL] [Abstract][Full Text] [Related]
9. Immune based therapy update.
Proj Inf Perspect; 1998 Sep; (25):17-9. PubMed ID: 11365845
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 immunogen (remune).
Newsline People AIDS Coalit N Y; 1998 Dec; ():36. PubMed ID: 11367099
[TBL] [Abstract][Full Text] [Related]
12. Remune. Immune Response.
Lai D; Jones T
Curr Opin Investig Drugs; 2002 Mar; 3(3):391-8. PubMed ID: 12054085
[TBL] [Abstract][Full Text] [Related]
13. Remune trial ended.
Res Initiat Treat Action; 1999 Jul; 5(3):28. PubMed ID: 11366725
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha and human immunodeficiency virus-specific functional immune responses after immunization with Gp120-depleted, inactivated HIV-1 in incomplete Freund's adjuvant (REMUNE) in HIV-1-seropositive subjects.
Moss RB; Li L; Giermakowska WK; Lanza P; Turner JL; Wallace MR; Jensen FC; Richieri SP; Daigle AE; Theofan G; Carlo DJ
J Hum Virol; 1998; 1(2):77-81. PubMed ID: 10195235
[TBL] [Abstract][Full Text] [Related]
15. In brief: immune based therapies.
Proj Inf Perspect; 1999 Sep; (28):24. PubMed ID: 11367364
[TBL] [Abstract][Full Text] [Related]
16. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
18. Salk's HIV immunogen: an immune-based therapy in human trials since 1988.
Crit Path AIDS Proj; 1994-1995 Winter; (No 30):1, 20-3. PubMed ID: 11362152
[TBL] [Abstract][Full Text] [Related]
19. FDA advisory committees meet January 26 on Salk HIV-1 immunogen.
AIDS Treat News; 1995 Jan; (No 214):1-2. PubMed ID: 11362184
[TBL] [Abstract][Full Text] [Related]
20. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
